Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

‘Wendy’s E. coli outbreak sickens more than 100 as lawsuits pile up’ -New York Post

https://nypost.com/2022/08/23/wendys-e-coli-outbreak-sickens-more-than-100-as-lawsuits-pile-up/?utm_campaign=SocialFlow&utm_medium=SocialFlow&utm_source=nypbusinesstwitter

byMichael Horton

August 23, 2022

1 minute read

https://nypost.com/2022/08/23/wendys-e-coli-outbreak-sickens-more-than-100-as-lawsuits-pile-up/?utm_campaign=SocialFlow&utm_medium=SocialFlow&utm_source=nypbusinesstwitter

Roth Capital Maintains Buy on Landec, Raises Price Target to $15

By Benzinga Newsdesk

July 30, 9:45 AM

Roth Capital maintains Landec (NASDAQ:LNDC) with a Buy and raises the price target from $12 to $15.

LNDC

Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial

By Vandana Singh

August 25, 8:12 AM

Lipocine Inc (NASDAQ: LPCN) has

LPCN

JP Morgan Downgrades Noah Holdings to Neutral, Announces $50 Price Target

By Benzinga Newsdesk

November 24, 9:53 AM

JP Morgan analyst Katherine Lei downgrades Noah Holdings (NYSE:NOAH) from Overweight to Neutral and announces $50 price target.

NOAH

Guild Holdings Q4 EPS $0.69 Beats $0.61 Estimate, Sales $343.10M Miss $365.70M Estimate

By Benzinga Newsdesk

March 10, 5:19 PM

Guild Holdings (NYSE:GHLD) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.61 by 13.11 percent. This is a 53.69 percent decrease over earnings of $1.49 per share from the

GHLD

‘Wendy’s E. coli outbreak sickens more than 100 as lawsuits pile up’ -New York Post

Related Posts

Roth Capital Maintains Buy on Landec, Raises Price Target to $15

Lipocine Meets Resolution Regulatory Endpoint In Mid-Stage NASH Trial

JP Morgan Downgrades Noah Holdings to Neutral, Announces $50 Price Target

Guild Holdings Q4 EPS $0.69 Beats $0.61 Estimate, Sales $343.10M Miss $365.70M Estimate